Insider: Avalon Ventures XI, L.P. Other - Janux Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,629,085 | 509,273 | 3,138,358 |
| Value | $38,148,023.35 | $7,389,551.23 | $45,537,574.58 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 10/18/2024 | DDS | 19,900 | Indirect | COM | $50.30 | $1,000,970.00 | 509,273 |
| 10/18/2024 | DDS | 102,732 | Direct | COM | $50.30 | $5,167,419.60 | 2,629,085 |
| 10/18/2024 | DDS | 553,219 | Indirect | COM | $44.75 | $24,756,550.25 | 2,115,373 |
| 10/18/2024 | DDS | 15,462 | Direct | COM | $51.18 | $791,345.16 | 2,613,623 |
| 10/18/2024 | DDS | 104,892 | Indirect | COM | $50.30 | $5,276,067.60 | 2,684,380 |
| 10/18/2024 | DDS | 104,957 | Indirect | COM | $44.75 | $4,696,825.75 | 401,321 |
| 10/18/2024 | DDS | 2,995 | Indirect | COM | $51.18 | $153,284.10 | 506,278 |
| 10/18/2024 | DDS | 541,824 | Direct | COM | $44.75 | $24,246,624.00 | 2,071,799 |
| 10/18/2024 | DDS | 15,788 | Indirect | COM | $51.18 | $808,029.84 | 2,668,592 |
| 10/17/2024 | DDS | 1,843 | Direct | COM | $50.02 | $92,186.86 | 6,371 |
| 10/16/2024 | DDS | 11,657 | Indirect | COM | $49.69 | $579,236.33 | 534,883 |
| 10/16/2024 | DDS | 61,445 | Indirect | COM | $49.69 | $3,053,202.05 | 2,819,366 |
| 10/16/2024 | DDS | 60,179 | Direct | COM | $49.69 | $2,990,294.51 | 2,761,291 |
| 10/16/2024 | DDS | 10,957 | Direct | COM | $50.80 | $556,615.60 | 6,445 |
| 10/16/2024 | DDS | 30,094 | Indirect | COM | $50.61 | $1,523,057.34 | 2,789,272 |
| 10/16/2024 | DDS | 5,710 | Indirect | COM | $50.61 | $288,983.10 | 529,173 |
| 10/16/2024 | DDS | 29,474 | Direct | COM | $50.61 | $1,491,679.14 | 2,731,817 |
| 09/30/2024 | DDS | 958 | Direct | COM | $46.24 | $44,297.92 | 6,887 |
| 09/27/2024 | DDS | 46,861 | Indirect | COM | $46.42 | $2,175,287.62 | 2,882,353 |
| 09/27/2024 | DDS | 8,894 | Indirect | COM | $46.42 | $412,859.48 | 546,833 |
| 09/27/2024 | DDS | 1,511 | Direct | COM | $47.74 | $72,135.14 | 2,821,470 |
| 09/27/2024 | DDS | 45,894 | Direct | COM | $46.42 | $2,130,399.48 | 2,822,981 |
| 09/27/2024 | DDS | 293 | Indirect | COM | $47.74 | $13,987.82 | 546,540 |
| 09/27/2024 | DDS | 1,826 | Direct | COM | $46.19 | $84,342.94 | 6,926 |
| 09/27/2024 | DDS | 1,542 | Indirect | COM | $47.74 | $73,615.08 | 2,880,811 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research